ALTIMMUNE, INC. Debt Instrument, Convertible, Number of Equity Instruments
ALTIMMUNE, INC. (ALT) had Debt Instrument, Convertible, Number of Equity Instruments of 1055800.00% as of 2017-05-04, per its 10-K filed 2019-04-01.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments · last filed 2019-04-01
- 2017-05-04: Debt Instrument, Convertible, Number of Equity Instruments 1055800.00%; Debt Instrument, Convertible, Number of Equity Instruments as first filed 31673500.00%.
| Period end | Debt Instrument, Convertible, Number of Equity Instruments | Debt Instrument, Convertible, Number of Equity Instruments as first filed |
|---|---|---|
| 2017-05-04 | 1055800.00% 10-K · filed 2019-04-01 | 31673500.00% 10-Q · filed 2017-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |